OMOP Concept 43043801

226 ML Atovaquone 150 MG/ML Oral Suspension [Wellvone] by Glaxosmithkline

StandardDrugRxNorm ExtensionOMOP4858814Marketed Product

Maps from

Descendants

Valid from

6 Oct 2019

Valid to

31 Dec 2099

OMOP concepts

Concept Lookup Tool

Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.

Or try

Diabetes Hypertension Aspirin

Source codes that map to this concept

2 source codes normalize to 226 ML Atovaquone 150 MG/ML Oral Suspension [Wellvone] by Glaxosmithkline via the OMOP "Maps to" relationship.

Vocabulary	Code	Name	Type
BDPM	3657278	WELLVONE 750 mg/5 ml, suspension buvable	Non-standard
dm+d	16590911000001104	Wellvone 750mg/5ml oral suspension (GlaxoSmithKline UK Ltd) 226 ml	Non-standard

Where it sits in the hierarchy

Ordered by distance - 1 is a direct parent or child.

Broader concepts

(53)

Roll up to these when you need a wider cohort.

Get this concept via the API

Resolve 226 ML Atovaquone 150 MG/ML Oral Suspension [Wellvone] by Glaxosmithkline - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.

curl "https://api.omophub.com/v1/concepts/43043801?include_relationships=true" \
  -H "Authorization: Bearer $OMOPHUB_API_KEY"

Get your free API key3,000 calls/month free · no credit card